The main contents of today’s Sci tech Innovation Board evening news are as follows: the CSRC said that it should take the full implementation of the stock issuance registration system as the main line to further promote the reform of the capital market; Shenzhen Xinyichang Technology Co.Ltd(688383) , Infovision Optoelectronics (Kunshan) Co.Ltd(688055) etc. release the performance pre increase report for 2021.
[hotspot Focus]
CSRC: we should take the full implementation of the stock issuance registration system as the main line to further promote the reform of the capital market
China Securities Regulatory Commission held the 2022 system working meeting on July 17. The meeting stressed the need to comprehensively implement the stock issuance registration system as the main line and further promote the reform of the capital market. Adhere to the “three principles” of the reform of the registration system, make full “embroidery” efforts, and make practical preparations for fine thinking, business and clean government. Further improve the registration system arrangement with information disclosure as the core, highlight the top priority of the main board reform, accelerate the transformation of issuance supervision, further compact the “gatekeeper” responsibility of intermediaries, enhance the joint efforts of all parties, promote the formation of a good market ecology conducive to the full implementation of the registration system, and ensure the smooth implementation of the reform. At the same time, we will comprehensively improve the multi-level market system, simultaneously promote the reform of the basic system and the self construction of the CSRC system, and continuously deepen the reform of the capital market.
the Ministry of industry and information technology organized and held the working meeting of intelligent Internet connected vehicle promotion group (icv-2035)
The first equipment industry department of the Ministry of industry and information technology recently organized a working meeting of the intelligent networked vehicle promotion group (icv-2035). The meeting pointed out that in 2022, the intelligent connected vehicle promotion group (icv-2035) will grasp the new situation of industrial development, focus on key problems, strengthen technology research and development, coordinate relevant work of technological innovation and industrialization, and promote the development of intelligent connected vehicle industry to achieve new results.
Bureau of Statistics: in 2021, the output of new energy vehicles, industrial Siasun Robot&Automation Co.Ltd(300024) , integrated circuits and microcomputer equipment increased by 145.6%, 44.9%, 33.3% and 22.3% respectively
According to the data of the National Bureau of statistics, in 2021, the added value of industries above designated size increased by 9.6% over the previous year, with an average growth of 6.1% in the two years. In terms of three categories, the added value of mining industry increased by 5.3%, manufacturing industry increased by 9.8%, and power, heat, gas and water production and supply industry increased by 11.4%. The added value of high-tech manufacturing and equipment manufacturing increased by 18.2% and 12.9% respectively, 8.6 and 3.3 percentage points faster than that of industries above designated size. By product, the output of new energy vehicles, industrial Siasun Robot&Automation Co.Ltd(300024) , integrated circuits and microcomputer equipment increased by 145.6%, 44.9%, 33.3% and 22.3% respectively. In 2021, the utilization rate of national industrial capacity was 77.5%, an increase of 3.0 percentage points over the previous year.
vv116, China’s first covid-19 oral drug, is expected to apply for listing in the second half of the year
The only covid-19 small molecule drug vv116 approved for clinical trial in China will start the application for marketing (NDA) as soon as it passes the clinical trial within this year. Preclinical pharmacodynamic studies showed that vv116 had significant inhibitory activity against the original and variant strains of covid-19 virus, such as delta virus, in vitro. The enterprise evaluation is expected to submit the listing (NDA) application in the second half of 2022. China’s listing application is advancing simultaneously.
Baidu announced interconnection with more than 10 enterprises such as meituan and xiaohongshu
The reporter of the science and Innovation Board daily learned that Baidu, together with more than 10 enterprises such as meituan, xiaohongshu, Shunfeng, Ctrip, Zhihu, Tongcheng, cat’s eye and 58 in the same city, announced the opening of in-depth connectivity cooperation, and will start with the Spring Festival and carry out connectivity cooperation at the three levels of traffic, technology and service ecology. It is understood that the above-mentioned more than ten enterprises have launched intelligent applets in Baidu app. Baidu will open 10 billion traffic to interconnection partners during this year’s “year of good luck China” activity.
[announcement of science and innovation board]
three Sci-tech Innovation Board companies issued the announcement of pre increase of performance in 2021
Shanghai Shen Lian Biomedical Corporation(688098) performance express: the net profit attributable to the parent company in 2021 decreased by 19.39% to 104 million yuan
Shanghai Shen Lian Biomedical Corporation(688098) announced the announcement of 2021 annual performance express. In 2021, the company achieved a total operating revenue of 358 million yuan, a year-on-year increase of 6.13%; The total profit was 119 million yuan, a year-on-year decrease of 20.38%; The net profit attributable to the owners of the parent company was 104 million yuan, a year-on-year decrease of 19.39%; The net profit attributable to the owner of the parent company after deducting non recurring profits and losses was 92.50506 million yuan, a year-on-year decrease of 15.96%; The basic earnings per share is 0.25 yuan.
Frontier Biotechnologies Inc(688221) : the product fb2001 is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia
Frontier Biotechnologies Inc(688221) announced the share price change. The company’s product fb2001 under development is a covid-19 pneumonia virus protease inhibitor for injection, and the target is covid-19 pneumonia virus 3CL main protease. As of the disclosure date of this announcement, Pfizer’s oral covid-19 drug (paxlovid) has been authorized by the U.S. Food and Drug Administration (FDA) for emergency use, It is used to treat non hospitalized patients with mild to moderate covid-19 pneumonia with adverse prognosis risk. The company’s product fb2001 is a protease inhibitor for injection, which is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia.
Shanghai Zj Bio-Tech Co.Ltd(688317) : shareholders pan Xin Investment and Ningbo ruidao plan to reduce their shares by no more than 6%
Shanghai Zj Bio-Tech Co.Ltd(688317) it is announced that the shareholders pan Xin Investment and Ningbo ruidao plan to reduce their shares by no more than 6%.
Zhuzhou Huarui Precision Cutting Tools.Co.Ltd(688059) : received the second round of audit inquiry letter on the application for issuing convertible bonds to unspecified objects
According to the announcement of Zhuzhou Huarui Precision Cutting Tools.Co.Ltd(688059) , the company received the second round examination and inquiry letter on Zhuzhou Huarui Precision Cutting Tools.Co.Ltd(688059) application documents for issuing convertible bonds to unspecified objects (szkss (refinancing) [2022] No. 11) issued by Shanghai Stock Exchange (“Shanghai Stock Exchange”) on January 16, 2022. The audit institution of Shanghai Stock Exchange reviewed the application documents submitted by the company for issuing convertible corporate bonds to unspecified objects (hereinafter referred to as “this issuance”) and formed the second round of questions.
Ucap Cloud Information Technology Co.Ltd(688228) : add Yang Chunyu as the core technician
Ucap Cloud Information Technology Co.Ltd(688228) announcement: the company newly identified Yang Chunyu as the company’s core technical personnel.
As of the disclosure date of this announcement, the company’s core technicians are: Wang Min, Liu Xuanshan, Zhou Jian, Wang Jing and Yang Chunyu.
Hangzhou Kelin Electric Co.Ltd(688611) : it is proposed to launch the restricted stock incentive plan in 2022
Hangzhou Kelin Electric Co.Ltd(688611) announce the restricted stock incentive plan (Draft) for 2022. The number of restricted shares to be granted to incentive objects in the incentive plan shall not exceed 1.3 million shares, accounting for 2.33% of the total share capital of the company at the time of announcement of the draft incentive plan. The grant price (including reserved grant) of restricted shares in the plan is 41 yuan / share. The total number of incentive objects to be granted in the incentive plan for the first time is 66, accounting for 29.73% of the total number of 222 employees of the company (as of December 31, 2021). They are the directors, senior managers, core technicians, middle managers, technical backbone and business backbone of the company or its subsidiaries when the company announced the incentive plan, but do not include the independent directors and supervisors of the company.
Cabio Biotech (Wuhan) Co.Ltd(688089) : it is proposed to launch the restricted stock incentive plan in 2022
Cabio Biotech (Wuhan) Co.Ltd(688089) announce the restricted stock incentive plan (Draft) for 2022. The number of restricted shares to be granted in the incentive plan is 1.8 million shares, accounting for 1.50% of the total share capital of the company at the time of announcement of the draft incentive plan. The grant price (including reserved grant) of restricted shares in the plan is 29.26 yuan / share.
[issuance and approval status]
Update of issuance status of 3 companies to be listed on the science and innovation board
As of press time, a total of 713 companies’ applications for listing on the science and innovation board have been accepted, and the issuance and approval status of 3 companies has been updated.
Among them, Sany Heavy energy was adopted at the municipal Party committee meeting; Peggy biology and Melander medical have inquired.
[venture capital vane]
speed of light China leading investment Minqiao technology tens of millions of Yuan seed round financing
Minqiao technology announced the completion of tens of millions of Yuan seed round financing, led by Lightspeed China, followed by Sequoia China seed fund, Miracle Automation Engineering Co.Ltd(002009) and paradigm fund. This round of financing will be used for R & D and team building of its core product PCP. It is reported that the core product PCP of Minqiao technology is a digital R & D platform equipped with PLM (product life cycle management) + CAD full stack SaaS tools, which can support high-end manufacturing industries such as automobile and aerospace to realize efficient digital transformation and improve the coordination efficiency of R & D engineers. The reporter of science and Innovation Board daily learned that in the future, Minqiao will expand the user scale of small and medium-sized enterprises and gradually develop from automobile manufacturing industry to electric bicycle, machinery manufacturing, household appliances and other industries.
Qiming venture capital and meituan participated in the a + + round of 800 million yuan financing of Aixin Yuanzhi
The reporter of science and technology innovation board daily learned that AI vision chip developer Aisin Yuanzhi completed the a + + round of financing, with a total amount of 800 million yuan. Qiming venture capital, Weihao Chuangxin, meituan and meituan Longzhu, Heju capital, Jiyuan capital, Lenovo star and Yaotu capital jointly participated in this round of financing. This financing will be used to introduce industrial resources, attract top talents in the industry, expand business scale and build industrial cooperation.
source capital and Qiming venture capital jointly lead the investment in Shenzhen potential technology
Shenzhen potential technology, which is engaged in “Ai + molecular simulation” technology, announced the completion of tens of millions of dollars in round B financing. The reporter learned that this round of financing is jointly led by source capital and Qiming venture capital, followed by old shareholders Gaoling venture capital and Jingwei venture capital, and miracle capital serves as the exclusive FA. Previously, Shenzhen potential technology has completed four consecutive rounds of financing within 18 months, and the funds will be used for the landing of relevant technologies in drug, material design and other scenes, as well as deepening the construction of micro scale industrial design platform.
